nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Tearfulness—Imiquimod—skin cancer	0.0991	0.0991	CcSEcCtD
Flumazenil—Crying—Imiquimod—skin cancer	0.0569	0.0569	CcSEcCtD
Flumazenil—Hyperacusis—Temozolomide—skin cancer	0.02	0.02	CcSEcCtD
Flumazenil—Supraventricular tachycardia—Imiquimod—skin cancer	0.019	0.019	CcSEcCtD
Flumazenil—Rigors—Vemurafenib—skin cancer	0.0178	0.0178	CcSEcCtD
Flumazenil—Rigors—Imiquimod—skin cancer	0.0152	0.0152	CcSEcCtD
Flumazenil—Aggression—Bleomycin—skin cancer	0.01	0.01	CcSEcCtD
Flumazenil—Nasal congestion—Imiquimod—skin cancer	0.0099	0.0099	CcSEcCtD
Flumazenil—Scotoma—Temozolomide—skin cancer	0.0098	0.0098	CcSEcCtD
Flumazenil—Rigors—Temozolomide—skin cancer	0.00912	0.00912	CcSEcCtD
Flumazenil—Speech disorder—Temozolomide—skin cancer	0.00865	0.00865	CcSEcCtD
Flumazenil—Speech disorder—Fluorouracil—skin cancer	0.00797	0.00797	CcSEcCtD
Flumazenil—Hearing impaired—Temozolomide—skin cancer	0.00782	0.00782	CcSEcCtD
Flumazenil—Sweating increased—Imiquimod—skin cancer	0.00759	0.00759	CcSEcCtD
Flumazenil—Supraventricular tachycardia—Docetaxel—skin cancer	0.00755	0.00755	CcSEcCtD
Flumazenil—Redness—Docetaxel—skin cancer	0.00733	0.00733	CcSEcCtD
Flumazenil—Fatigue—Vismodegib—skin cancer	0.00725	0.00725	CcSEcCtD
Flumazenil—Pain—Vismodegib—skin cancer	0.00719	0.00719	CcSEcCtD
Flumazenil—Depressed level of consciousness—Temozolomide—skin cancer	0.00719	0.00719	CcSEcCtD
Flumazenil—Chills—Vemurafenib—skin cancer	0.00656	0.00656	CcSEcCtD
Flumazenil—Scotoma—Docetaxel—skin cancer	0.00652	0.00652	CcSEcCtD
Flumazenil—Abnormal vision—Temozolomide—skin cancer	0.00649	0.00649	CcSEcCtD
Flumazenil—Erythema—Vemurafenib—skin cancer	0.00637	0.00637	CcSEcCtD
Flumazenil—Thrombophlebitis—Temozolomide—skin cancer	0.00624	0.00624	CcSEcCtD
Flumazenil—Rigors—Docetaxel—skin cancer	0.00606	0.00606	CcSEcCtD
Flumazenil—Deafness—Temozolomide—skin cancer	0.00604	0.00604	CcSEcCtD
Flumazenil—Asthenia—Vismodegib—skin cancer	0.00603	0.00603	CcSEcCtD
Flumazenil—Visual impairment—Imiquimod—skin cancer	0.00601	0.00601	CcSEcCtD
Flumazenil—Pruritus—Vismodegib—skin cancer	0.00595	0.00595	CcSEcCtD
Flumazenil—Nasal congestion—Temozolomide—skin cancer	0.00593	0.00593	CcSEcCtD
Flumazenil—Euphoric mood—Fluorouracil—skin cancer	0.00589	0.00589	CcSEcCtD
Flumazenil—Tinnitus—Imiquimod—skin cancer	0.00582	0.00582	CcSEcCtD
Flumazenil—Flushing—Imiquimod—skin cancer	0.00579	0.00579	CcSEcCtD
Flumazenil—Hot flush—Temozolomide—skin cancer	0.00578	0.00578	CcSEcCtD
Flumazenil—Thrombophlebitis—Fluorouracil—skin cancer	0.00575	0.00575	CcSEcCtD
Flumazenil—Menopausal symptoms—Temozolomide—skin cancer	0.00573	0.00573	CcSEcCtD
Flumazenil—Chills—Imiquimod—skin cancer	0.0056	0.0056	CcSEcCtD
Flumazenil—Arrhythmia—Imiquimod—skin cancer	0.00557	0.00557	CcSEcCtD
Flumazenil—Cough—Vemurafenib—skin cancer	0.00556	0.00556	CcSEcCtD
Flumazenil—Erythema—Imiquimod—skin cancer	0.00543	0.00543	CcSEcCtD
Flumazenil—Diplopia—Temozolomide—skin cancer	0.0054	0.0054	CcSEcCtD
Flumazenil—Vomiting—Vismodegib—skin cancer	0.00535	0.00535	CcSEcCtD
Flumazenil—Affect lability—Temozolomide—skin cancer	0.00532	0.00532	CcSEcCtD
Flumazenil—Rash—Vismodegib—skin cancer	0.0053	0.0053	CcSEcCtD
Flumazenil—Dermatitis—Vismodegib—skin cancer	0.0053	0.0053	CcSEcCtD
Flumazenil—Hearing impaired—Docetaxel—skin cancer	0.0052	0.0052	CcSEcCtD
Flumazenil—Mood swings—Temozolomide—skin cancer	0.00512	0.00512	CcSEcCtD
Flumazenil—Ataxia—Temozolomide—skin cancer	0.00508	0.00508	CcSEcCtD
Flumazenil—Ill-defined disorder—Imiquimod—skin cancer	0.00504	0.00504	CcSEcCtD
Flumazenil—Nausea—Vismodegib—skin cancer	0.005	0.005	CcSEcCtD
Flumazenil—Agitation—Imiquimod—skin cancer	0.00499	0.00499	CcSEcCtD
Flumazenil—Injection site reaction—Docetaxel—skin cancer	0.00492	0.00492	CcSEcCtD
Flumazenil—Malaise—Imiquimod—skin cancer	0.0049	0.0049	CcSEcCtD
Flumazenil—Hypotension—Vemurafenib—skin cancer	0.00486	0.00486	CcSEcCtD
Flumazenil—Palpitations—Imiquimod—skin cancer	0.0048	0.0048	CcSEcCtD
Flumazenil—Cough—Imiquimod—skin cancer	0.00474	0.00474	CcSEcCtD
Flumazenil—Hypertension—Imiquimod—skin cancer	0.00469	0.00469	CcSEcCtD
Flumazenil—Ataxia—Fluorouracil—skin cancer	0.00468	0.00468	CcSEcCtD
Flumazenil—Chest pain—Imiquimod—skin cancer	0.00462	0.00462	CcSEcCtD
Flumazenil—Anxiety—Imiquimod—skin cancer	0.00461	0.00461	CcSEcCtD
Flumazenil—Discomfort—Imiquimod—skin cancer	0.00457	0.00457	CcSEcCtD
Flumazenil—Sweating increased—Temozolomide—skin cancer	0.00455	0.00455	CcSEcCtD
Flumazenil—Dry mouth—Imiquimod—skin cancer	0.00452	0.00452	CcSEcCtD
Flumazenil—Fatigue—Vemurafenib—skin cancer	0.00448	0.00448	CcSEcCtD
Flumazenil—Hypoaesthesia—Bleomycin—skin cancer	0.00441	0.00441	CcSEcCtD
Flumazenil—Tachycardia—Imiquimod—skin cancer	0.00432	0.00432	CcSEcCtD
Flumazenil—Hyperhidrosis—Imiquimod—skin cancer	0.00428	0.00428	CcSEcCtD
Flumazenil—Thrombophlebitis—Docetaxel—skin cancer	0.00415	0.00415	CcSEcCtD
Flumazenil—Flushing—Bleomycin—skin cancer	0.00411	0.00411	CcSEcCtD
Flumazenil—Deafness—Docetaxel—skin cancer	0.00402	0.00402	CcSEcCtD
Flumazenil—Insomnia—Imiquimod—skin cancer	0.00401	0.00401	CcSEcCtD
Flumazenil—Paraesthesia—Imiquimod—skin cancer	0.00398	0.00398	CcSEcCtD
Flumazenil—Chills—Bleomycin—skin cancer	0.00398	0.00398	CcSEcCtD
Flumazenil—Dyspnoea—Imiquimod—skin cancer	0.00395	0.00395	CcSEcCtD
Flumazenil—Somnolence—Imiquimod—skin cancer	0.00394	0.00394	CcSEcCtD
Flumazenil—Erythema—Bleomycin—skin cancer	0.00386	0.00386	CcSEcCtD
Flumazenil—Hot flush—Docetaxel—skin cancer	0.00384	0.00384	CcSEcCtD
Flumazenil—Flushing—Dactinomycin—skin cancer	0.00384	0.00384	CcSEcCtD
Flumazenil—Hypersensitivity—Vemurafenib—skin cancer	0.00383	0.00383	CcSEcCtD
Flumazenil—Fatigue—Imiquimod—skin cancer	0.00382	0.00382	CcSEcCtD
Flumazenil—Menopausal symptoms—Docetaxel—skin cancer	0.00381	0.00381	CcSEcCtD
Flumazenil—Pain—Imiquimod—skin cancer	0.00379	0.00379	CcSEcCtD
Flumazenil—Asthenia—Vemurafenib—skin cancer	0.00373	0.00373	CcSEcCtD
Flumazenil—Hypoaesthesia—Temozolomide—skin cancer	0.00372	0.00372	CcSEcCtD
Flumazenil—Hallucination—Temozolomide—skin cancer	0.00372	0.00372	CcSEcCtD
Flumazenil—Chills—Dactinomycin—skin cancer	0.00371	0.00371	CcSEcCtD
Flumazenil—Pruritus—Vemurafenib—skin cancer	0.00368	0.00368	CcSEcCtD
Flumazenil—Feeling abnormal—Imiquimod—skin cancer	0.00365	0.00365	CcSEcCtD
Flumazenil—Visual impairment—Temozolomide—skin cancer	0.0036	0.0036	CcSEcCtD
Flumazenil—Erythema—Dactinomycin—skin cancer	0.0036	0.0036	CcSEcCtD
Flumazenil—Ill-defined disorder—Bleomycin—skin cancer	0.00358	0.00358	CcSEcCtD
Flumazenil—Urticaria—Imiquimod—skin cancer	0.00352	0.00352	CcSEcCtD
Flumazenil—Tinnitus—Temozolomide—skin cancer	0.00349	0.00349	CcSEcCtD
Flumazenil—Malaise—Bleomycin—skin cancer	0.00348	0.00348	CcSEcCtD
Flumazenil—Flushing—Temozolomide—skin cancer	0.00347	0.00347	CcSEcCtD
Flumazenil—Dizziness—Vemurafenib—skin cancer	0.00344	0.00344	CcSEcCtD
Flumazenil—Hypoaesthesia—Fluorouracil—skin cancer	0.00343	0.00343	CcSEcCtD
Flumazenil—Ataxia—Docetaxel—skin cancer	0.00338	0.00338	CcSEcCtD
Flumazenil—Cough—Bleomycin—skin cancer	0.00337	0.00337	CcSEcCtD
Flumazenil—Chills—Temozolomide—skin cancer	0.00335	0.00335	CcSEcCtD
Flumazenil—Ill-defined disorder—Dactinomycin—skin cancer	0.00334	0.00334	CcSEcCtD
Flumazenil—Vomiting—Vemurafenib—skin cancer	0.0033	0.0033	CcSEcCtD
Flumazenil—Chest pain—Bleomycin—skin cancer	0.00328	0.00328	CcSEcCtD
Flumazenil—Rash—Vemurafenib—skin cancer	0.00328	0.00328	CcSEcCtD
Flumazenil—Dermatitis—Vemurafenib—skin cancer	0.00327	0.00327	CcSEcCtD
Flumazenil—Hypersensitivity—Imiquimod—skin cancer	0.00326	0.00326	CcSEcCtD
Flumazenil—Headache—Vemurafenib—skin cancer	0.00326	0.00326	CcSEcCtD
Flumazenil—Erythema—Temozolomide—skin cancer	0.00325	0.00325	CcSEcCtD
Flumazenil—Discomfort—Bleomycin—skin cancer	0.00324	0.00324	CcSEcCtD
Flumazenil—Malaise—Dactinomycin—skin cancer	0.00324	0.00324	CcSEcCtD
Flumazenil—Asthenia—Imiquimod—skin cancer	0.00318	0.00318	CcSEcCtD
Flumazenil—Confusional state—Bleomycin—skin cancer	0.00317	0.00317	CcSEcCtD
Flumazenil—Pruritus—Imiquimod—skin cancer	0.00314	0.00314	CcSEcCtD
Flumazenil—Nausea—Vemurafenib—skin cancer	0.00309	0.00309	CcSEcCtD
Flumazenil—Arrhythmia—Fluorouracil—skin cancer	0.00308	0.00308	CcSEcCtD
Flumazenil—Vision blurred—Temozolomide—skin cancer	0.00307	0.00307	CcSEcCtD
Flumazenil—Tremor—Temozolomide—skin cancer	0.00305	0.00305	CcSEcCtD
Flumazenil—Discomfort—Dactinomycin—skin cancer	0.00303	0.00303	CcSEcCtD
Flumazenil—Ill-defined disorder—Temozolomide—skin cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Erythema—Fluorouracil—skin cancer	0.003	0.003	CcSEcCtD
Flumazenil—Agitation—Temozolomide—skin cancer	0.00299	0.00299	CcSEcCtD
Flumazenil—Hypotension—Bleomycin—skin cancer	0.00294	0.00294	CcSEcCtD
Flumazenil—Malaise—Temozolomide—skin cancer	0.00293	0.00293	CcSEcCtD
Flumazenil—Dizziness—Imiquimod—skin cancer	0.00293	0.00293	CcSEcCtD
Flumazenil—Vertigo—Temozolomide—skin cancer	0.00292	0.00292	CcSEcCtD
Flumazenil—Palpitations—Temozolomide—skin cancer	0.00288	0.00288	CcSEcCtD
Flumazenil—Cough—Temozolomide—skin cancer	0.00284	0.00284	CcSEcCtD
Flumazenil—Paraesthesia—Bleomycin—skin cancer	0.00283	0.00283	CcSEcCtD
Flumazenil—Vision blurred—Fluorouracil—skin cancer	0.00283	0.00283	CcSEcCtD
Flumazenil—Vomiting—Imiquimod—skin cancer	0.00282	0.00282	CcSEcCtD
Flumazenil—Hypertension—Temozolomide—skin cancer	0.00281	0.00281	CcSEcCtD
Flumazenil—Dyspnoea—Bleomycin—skin cancer	0.00281	0.00281	CcSEcCtD
Flumazenil—Rash—Imiquimod—skin cancer	0.00279	0.00279	CcSEcCtD
Flumazenil—Dermatitis—Imiquimod—skin cancer	0.00279	0.00279	CcSEcCtD
Flumazenil—Headache—Imiquimod—skin cancer	0.00278	0.00278	CcSEcCtD
Flumazenil—Anxiety—Temozolomide—skin cancer	0.00276	0.00276	CcSEcCtD
Flumazenil—Discomfort—Temozolomide—skin cancer	0.00274	0.00274	CcSEcCtD
Flumazenil—Dry mouth—Temozolomide—skin cancer	0.00271	0.00271	CcSEcCtD
Flumazenil—Pain—Bleomycin—skin cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Confusional state—Temozolomide—skin cancer	0.00268	0.00268	CcSEcCtD
Flumazenil—Nausea—Imiquimod—skin cancer	0.00263	0.00263	CcSEcCtD
Flumazenil—Feeling abnormal—Bleomycin—skin cancer	0.00259	0.00259	CcSEcCtD
Flumazenil—Hyperhidrosis—Temozolomide—skin cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Chest pain—Fluorouracil—skin cancer	0.00255	0.00255	CcSEcCtD
Flumazenil—Fatigue—Dactinomycin—skin cancer	0.00253	0.00253	CcSEcCtD
Flumazenil—Discomfort—Fluorouracil—skin cancer	0.00252	0.00252	CcSEcCtD
Flumazenil—Pain—Dactinomycin—skin cancer	0.00251	0.00251	CcSEcCtD
Flumazenil—Urticaria—Bleomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Flumazenil—Hypoaesthesia—Docetaxel—skin cancer	0.00247	0.00247	CcSEcCtD
Flumazenil—Confusional state—Fluorouracil—skin cancer	0.00247	0.00247	CcSEcCtD
Flumazenil—Feeling abnormal—Dactinomycin—skin cancer	0.00242	0.00242	CcSEcCtD
Flumazenil—Insomnia—Temozolomide—skin cancer	0.0024	0.0024	CcSEcCtD
Flumazenil—Visual impairment—Docetaxel—skin cancer	0.0024	0.0024	CcSEcCtD
Flumazenil—Tachycardia—Fluorouracil—skin cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Paraesthesia—Temozolomide—skin cancer	0.00238	0.00238	CcSEcCtD
Flumazenil—Dyspnoea—Temozolomide—skin cancer	0.00237	0.00237	CcSEcCtD
Flumazenil—Somnolence—Temozolomide—skin cancer	0.00236	0.00236	CcSEcCtD
Flumazenil—Hypersensitivity—Bleomycin—skin cancer	0.00232	0.00232	CcSEcCtD
Flumazenil—Flushing—Docetaxel—skin cancer	0.00231	0.00231	CcSEcCtD
Flumazenil—Fatigue—Temozolomide—skin cancer	0.00229	0.00229	CcSEcCtD
Flumazenil—Hypotension—Fluorouracil—skin cancer	0.00229	0.00229	CcSEcCtD
Flumazenil—Pain—Temozolomide—skin cancer	0.00227	0.00227	CcSEcCtD
Flumazenil—Asthenia—Bleomycin—skin cancer	0.00226	0.00226	CcSEcCtD
Flumazenil—Chills—Docetaxel—skin cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Pruritus—Bleomycin—skin cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Arrhythmia—Docetaxel—skin cancer	0.00222	0.00222	CcSEcCtD
Flumazenil—Insomnia—Fluorouracil—skin cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Paraesthesia—Fluorouracil—skin cancer	0.0022	0.0022	CcSEcCtD
Flumazenil—Feeling abnormal—Temozolomide—skin cancer	0.00219	0.00219	CcSEcCtD
Flumazenil—Dyspnoea—Fluorouracil—skin cancer	0.00218	0.00218	CcSEcCtD
Flumazenil—Somnolence—Fluorouracil—skin cancer	0.00218	0.00218	CcSEcCtD
Flumazenil—Erythema—Docetaxel—skin cancer	0.00216	0.00216	CcSEcCtD
Flumazenil—Hypersensitivity—Dactinomycin—skin cancer	0.00216	0.00216	CcSEcCtD
Flumazenil—Urticaria—Temozolomide—skin cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Asthenia—Dactinomycin—skin cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Pain—Fluorouracil—skin cancer	0.00209	0.00209	CcSEcCtD
Flumazenil—Feeling abnormal—Fluorouracil—skin cancer	0.00202	0.00202	CcSEcCtD
Flumazenil—Vomiting—Bleomycin—skin cancer	0.002	0.002	CcSEcCtD
Flumazenil—Rash—Bleomycin—skin cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Dermatitis—Bleomycin—skin cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Hypersensitivity—Temozolomide—skin cancer	0.00196	0.00196	CcSEcCtD
Flumazenil—Urticaria—Fluorouracil—skin cancer	0.00194	0.00194	CcSEcCtD
Flumazenil—Palpitations—Docetaxel—skin cancer	0.00191	0.00191	CcSEcCtD
Flumazenil—Asthenia—Temozolomide—skin cancer	0.00191	0.00191	CcSEcCtD
Flumazenil—Cough—Docetaxel—skin cancer	0.00189	0.00189	CcSEcCtD
Flumazenil—Pruritus—Temozolomide—skin cancer	0.00188	0.00188	CcSEcCtD
Flumazenil—Nausea—Bleomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Flumazenil—Hypertension—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Flumazenil—Vomiting—Dactinomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Flumazenil—Rash—Dactinomycin—skin cancer	0.00185	0.00185	CcSEcCtD
Flumazenil—Chest pain—Docetaxel—skin cancer	0.00184	0.00184	CcSEcCtD
Flumazenil—Hypersensitivity—Fluorouracil—skin cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Dry mouth—Docetaxel—skin cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Confusional state—Docetaxel—skin cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Dizziness—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Flumazenil—Nausea—Dactinomycin—skin cancer	0.00174	0.00174	CcSEcCtD
Flumazenil—Pruritus—Fluorouracil—skin cancer	0.00173	0.00173	CcSEcCtD
Flumazenil—Tachycardia—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Flumazenil—Vomiting—Temozolomide—skin cancer	0.00169	0.00169	CcSEcCtD
Flumazenil—Rash—Temozolomide—skin cancer	0.00167	0.00167	CcSEcCtD
Flumazenil—Dermatitis—Temozolomide—skin cancer	0.00167	0.00167	CcSEcCtD
Flumazenil—Headache—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Hypotension—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Dizziness—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Flumazenil—Insomnia—Docetaxel—skin cancer	0.0016	0.0016	CcSEcCtD
Flumazenil—Paraesthesia—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Nausea—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Flumazenil—Dyspnoea—Docetaxel—skin cancer	0.00157	0.00157	CcSEcCtD
Flumazenil—Somnolence—Docetaxel—skin cancer	0.00157	0.00157	CcSEcCtD
Flumazenil—Vomiting—Fluorouracil—skin cancer	0.00156	0.00156	CcSEcCtD
Flumazenil—Rash—Fluorouracil—skin cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Dermatitis—Fluorouracil—skin cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Headache—Fluorouracil—skin cancer	0.00153	0.00153	CcSEcCtD
Flumazenil—Fatigue—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Pain—Docetaxel—skin cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Feeling abnormal—Docetaxel—skin cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Nausea—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Hypersensitivity—Docetaxel—skin cancer	0.0013	0.0013	CcSEcCtD
Flumazenil—Asthenia—Docetaxel—skin cancer	0.00127	0.00127	CcSEcCtD
Flumazenil—Pruritus—Docetaxel—skin cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Dizziness—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Vomiting—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Rash—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Dermatitis—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Headache—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Nausea—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
